Elevated Urine Zn Level of Diabetic Patients

Dunia Abdul Jabbar Star1, Muntadher Hussein Challoob2, Amer Hasan Abdullah*3 Ayat Mahmood Yahya4.

1Nurse Department, medical technical Institute, Middle Technical University

2,3 University of Mustansiriyah, College of Science, Chemistry Department

4Department of Scientific Affairs. Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad

*Corresponding Author :amerhasan1965@uomustansiriyah.edu.iq

Abstract

Zinc (Zn) is a crucial element in the human body. The deficit in individuals with diabetic nephropathy (DN) might be attributed to irritation and oxidative stress (OS). DN is a highly significant microvascular complication of diabetes mellitus (DM). Diabetes mellitus (DM) is a well-installed public fitness hassle due to its excessive occurrence and morbidity. The International Diabetes Federation predicts that the global prevalence of diabetes among the general population will rise to 300 million by 2025. Zinc deficiency and increased oxidative stress play a significant role in the development of diabetes complications. We aimed to research the relationships concentrations of Zn and pro-inflammatory elements with DN-related renal useful harm in sufferers with diabetes mellitus. In our current investigation, we found that the urinary zinc concentration in patients with DN is higher than that of healthy individuals. This finding may partially account for the lower serum zinc concentration observed in DN patients. This excessive urine zinc attention can be associated with polyuria. The low zinc degree with inside the diabetic sufferers can be because of the reduced gastrointestinal absorption and elevated urinary excretion.

Keywords: Diabetes, Hyperzincuria, Hypozincemia, Insulin, Zinc.

Introduction

Humans require zinc (Zn) as a hint element. One of the maximum large microvascular effects of diabetes mellitus (DM), diabetic nephropathy (DN) can be followed with irritation and oxidative pressure (OS) in sufferers . A famous public fitness problem because of its excessive occurrence and morbidity is diabetes mellitus (DM) (Nathan,2003). The International Diabetes Federation states that through 2025, three hundred million humans may have diabetes globally amongst the overall population (Ghazanfari et al.,2010). Zinc deficiency and increased oxidative stress significantly contribute to the development of diabetes complications (Afkhami–Ardekani et al.,2008). Our objective was to investigate the associations between concentrations of Zn and pro-inflammatory components and renal functional damage related to diabetic nephropathy in patients with diabetes mellitus (Ghazanfari et al.,2010). Zn play critical roles with inside the feature of diverse enzymes and transcription elements . Zinc exhibits anti-inflammatory effects and is involved in the internal activation of antioxidant proteins (Korkmaz-Icöz et al.,2016). Multiple previous studies have demonstrated zinc deficiency in patients with diabetes mellitus and diabetic nephropathy. It has been verified that Zn management hinders the activation of the nuclear factor kappa-B (NF-κB) signalling pathway, leading to a reduction in oxidative damage and the inflammatory response in the kidneys of rats with streptozotocin-induced diabetes. Zinc is an essential component of antioxidant enzymes, like as superoxide dismutase, which helps protect insulin and β cells from damage caused by free radicals (Jansen et al.,2009). However, contrary to this findings, hyperglycemia has been found to hinder the efficient transportation of zinc back to renal cells, resulting in the excretion of this mineral in the urine (Chausmer,1998). This suggests that the discovered association may also be characterized by the increased urine excretion of zinc in females who already had very high glucose levels at the beginning of the study.

Zinc and Insulin

The pancreatic beta cells launch insulin as a single-chain peptide joined through disulfide bonds. This proinsulin is reduced by casting off a C-peptide chain fragment to shape an insulin monomer that is made from (a- and b-) peptide chains including fifty-one amino acid residues and connected with every different through disulfide bond forces. Zinc is essential for the synthesis, storage, and release of the insulin hormone in the islet cells, as shown in Figure 1 (Li ,2014).The sensitivity of cells to insulin could be very crucial in sufferers with diabetes. Therefore, oxidative pressure and modifications inside the metabolism of zinc in cells cause an imbalance (modifies) in the sensitivity of cells to insulin. The deficiency of Zinc turns on oxidative pressure pathways which leads to a lack of tyrosine phosphatase control, main to insulin resistance (Haase and Maret,2005).

Figure 1: Role of zinc in insulin law and diabetes.

The Zinc homeostasis feature effect of DM on with inside the frame consists of hypozincemia, hyperzincuria, and compromised gastrointestinal absorption of nutritional Zn (Chausmer,1998). The Zn-poor instances may also exacerbate insulin resistance in type-2 diabetes mellitus. Hypozincemia is a result of hyperzincuria or impaired gastrointestinal absorption. Effects of zinc deficiency on diabetes mellitus insulin is stored in pancreatic β-cells in the form of a hexamer that includes zinc ions. Zinc, which is found within the islet cells of the pancreas, is associated with the production, storage, and release of insulin. (Dodson and Steiner,1998).The etiology of pathogenesis from diabetes is increased through oxidative stress (. Poitout and Robertson,2008). Since several antioxidant enzymes, which includes superoxide dismutase, have zinc as a structural component, a loss of Zn impacts the manufacturing of those enzyme proteins, which will increase oxidative stress. Zinc has been demonstrated to boost the interaction between insulin and its receptor, as well as improve the transportation of glucose by enhancing the process of tyrosine kinase phosphorylation in insulin signal transduction . Zinc is an integral component of antioxidant enzymes, like as superoxide dismutase, which helps protect insulin and β cells from damage caused by free radicals (Jansen et al.,2009). The diabetic condition, accompanied by hypozincemia and reduced tissue zinc concentration, is associated with the excretion of large amounts of zinc from the body. However, it is unclear whether the absence of Zn from the frame is solely due to hyperzincuria, impaired gastrointestinal absorption, or a combination of both( Narváez-Caicedo et al.,2018 ).

Discussion

Diabetes has been established as a leading cause of mortality worldwide. The prevalence of diabetes in developed nations constitutes a significant public health concern. Insulin is stored in secretory vesicles or granules, where Zn2+ ions coordinate six insulin monomers to form a hexameric structure, which then allows the formation of mature insulin crystals (Kimura and Kambe,2016). While trace elements are shown to be most effective in little quantities within the human body, they are highly crucial for human health. A first examination of the relationship between DM and trace elements revealed that maintaining proper homeostasis of trace elements aids in the regulation of blood glucose and mitigates tissue damage (Siddiqui et al.,2014 ). The hint factors are the key elements or clues that contribute to a solution or understanding of a problem or situation. Zinc is known to promote the amelioration of diabetes and its associated problems. Zinc (Zn) plays a crucial role in the internal creation, storage, and release of insulin by islet β-cells. Additionally, it safeguards the integrity of vascular endothelial cells by exerting anti-oxidative, anti-apoptotic, and membrane-stabilizing effects (Nazarizadeh A, Asri-Rezaie et al.,2016). Explained that low Zn visible inside the diabetic populace turned into because of the reduced gastrointestinal absorption and elevated urinary excretion (Zargar et al.,1998).

The identification of abnormally high urine excretion of zinc revealed a correlation with zinc deficiency in β cells, resulting in reduced insulin output. Specific zinc complexes have been verified to have an insulin-like effect, which includes reducing high blood sugar levels and increasing the production of fats in animal models. However, hyperglycemia has been found to hinder the efficient transport of zinc back to renal cells, resulting in the excretion of this mineral in the urine (Chausmer,1998). This suggests that the discovered association may also be characterized by the increased urine excretion of zinc in females who already had significantly elevated glucose levels at the beginning of the study (Figure 2).

Figure2: Hyperglycemia in diabetes mellitus has been related to lipid peroxidation and oxidative harm in cells

However, the low zinc levels in diabetic patients may be attributed to reduced absorption in the gastrointestinal tract and increased excretion through urine (Marchesini et al.,1998). Another possible cause is the alteration of other minerals, particularly copper (Kinlaw et al.,1983). Additionally, hyperglycemia may interfere with the active transport of zinc back into the renal tubular cells, leading to further urinary excretion of zinc ( Atari-Hajipirloo et al.,2016). Alternatively, Hyperglycemia and the resulting increase in glucose inside the kidney are responsible for hyperzincuria, as evidenced by a strong link between hemoglobin A1c levels and urine zinc excretion in individuals. However, it is unclear whether the simultaneous occurrence of hypozincemia and reduced tissue zinc stores in diabetic individuals is caused by hyperzincuria or is an independent effect of hyperglycemia on the depletion of zinc stores from the tissues, leading to a subsequent loss of zinc from circulation. An inverse relationship between fractional zinc shipping and metallothionein expression has been seen in diabetic patients (Maret,2000). Metallothioneins regulate the availability of zinc in β cells. When Zn is required for the synthesis of Zn proteins, the metallothioneins release Zn.

Conclusions

In the current investigation, we found that the urine zinc concentration in patients with DN is higher than that in healthy individuals, which may partially account for the lower serum zinc concentration in patients with DN. The elevated concentration of zinc in urine can be linked to excessive urination, high levels of blood glucose, the presence of glucose in urine, and/or protein in urine. As DN progressed, the levels of zinc in the urine decreased gradually. This decrease became considerable in patients with DN who had an estimated glomerular filtration rate (eGFR) of less than 15 ml min−1

1.73 m−2. This can be characterized by a decrease in urine volume or even anuria in patients with renal failure, and abnormal zinc metabolism is more prevalent in patients at this stage of diabetic nephropathy progression.

Acknowledgment

non

Conflicts of Interest

non

References

Afkhami-Ardekani, M., Karimi, M., Mohammadi, S. M., & Nourani, F. (2008). Effect of zinc sulfate supplementation on lipid and glucose in type 2 diabetic patients. Pak J Nutr, 7(4), 550-3.
Atari-Hajipirloo, S., Valizadeh, N., Khadem-Ansari, M. H., Rasmi, Y., & Kheradmand, F. (2016). Altered concentrations of copper, zinc, and iron are associated with increased levels of glycated hemoglobin in patients with type 2 diabetes mellitus and their first-degree relatives. International journal of endocrinology and metabolism, 14(2).
Chausmer, A. B. (1998). Zinc, insulin and diabetes. Journal of the American College of Nutrition, 17(2), 109-115.
Dodson, G., & Steiner, D. (1998). The role of assembly in insulin’s biosynthesis. Current opinion in structural biology, 8(2), 189-194.
Ghazanfari, Z., Haghdoost, A. A., Alizadeh, S. M., Atapour, J., & Zolala, F. (2010). A comparison of HbA1c and fasting blood sugar tests in general population. International journal of preventive medicine, 1(3), 187.
Haase, H., & Maret, W. (2005). Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals, 18, 333-338.
Jansen, J., Karges, W., & Rink, L. (2009). Zinc and diabetes—clinical links and molecular mechanisms. The Journal of nutritional biochemistry, 20(6), 399-417.
Jansen, J., Karges, W., & Rink, L. (2009). Zinc and diabetes—clinical links and molecular mechanisms. The Journal of nutritional biochemistry, 20(6), 399-417.
Kimura, T., & Kambe, T. (2016). The functions of metallothionein and ZIP and ZnT transporters: an overview and perspective. International Journal of Molecular Sciences, 17(3), 336.
Kinlaw, W. B., Levine, A. S., Morley, J. E., Silvis, S. E., & McClain, C. J. (1983). Abnormal zinc metabolism in type II diabetes mellitus. The American journal of medicine, 75(2), 273-277.
Korkmaz-Icöz, S., Atmanli, A., Radovits, T., Li, S., Hegedüs, P., Ruppert, M., … & Szabó, G. (2016). Administration of zinc complex of acetylsalicylic acid after the onset of myocardial injury protects the heart by upregulation of antioxidant enzymes. The Journal of Physiological Sciences, 66, 113-125.
Li, Y. V. (2014). Zinc and insulin in pancreatic beta-cells. Endocrine, 45, 178-189.
Marchesini, G., Bugianesi, E., Ronchi, M., Flamia, R., Thomaseth, K., & Pacini, G. (1998). Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism, 47(7), 792- 798.
Maret, W. (2000). The function of zinc metallothionein: a link between cellular zinc and redox state. The Journal of nutrition, 130(5), 1455S-1458S.
Narváez-Caicedo, C., Moreano, G., Sandoval, B. A., & Jara-Palacios, M. Á. (2018). Zinc deficiency among lactating mothers from a peri-urban community of the ecuadorian andean region: An initial approach to the need of zinc supplementation. Nutrients, 10(7), 869.
Nathan, D. M. (2003). Isolated pancreas transplantation for type 1 diabetes: a doctor’s dilemma. JAMA, 290(21), 2861-2863.
Nazarizadeh, A., & Asri-Rezaie, S. (2016). Comparative study of antidiabetic activity and oxidative stress induced by zinc oxide nanoparticles and zinc sulfate in diabetic rats. AAPS PharmSciTech, 17, 834-843.
Poitout, V., & Robertson, R. P. (2008). Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocrine reviews, 29(3), 351-366.
Siddiqui, K., Bawazeer, N., & Scaria Joy, S. (2014). Variation in macro and trace elements in progression of type 2 diabetes. The scientific world journal, 2014.
Zargar, A. H., Shah, N. A., Masoodi, S. R., Laway, B. A., Dar, F. A., Khan, A. R., … & Wani,
A. I. (1998). Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgraduate medical journal, 74(877), 665-668.